BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16230072)

  • 1. The risk of missed gastroesophageal cancer diagnoses in users and nonusers of antisecretory medication.
    Lassen A; Hallas J; de Muckadell OB
    Gastroenterology; 2005 Oct; 129(4):1179-86. PubMed ID: 16230072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-time endoscopy and use of antisecretory medication: a population-based cohort study.
    Lassen A; Hallas J; De Muckadell OB
    Scand J Gastroenterol; 2005 Jun; 40(6):705-12. PubMed ID: 16036531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed diagnoses in patients with upper gastrointestinal cancers.
    Yalamarthi S; Witherspoon P; McCole D; Auld CD
    Endoscopy; 2004 Oct; 36(10):874-9. PubMed ID: 15452783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
    Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
    Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer after repair of esophageal atresia: population-based long-term follow-up.
    Sistonen SJ; Koivusalo A; Lindahl H; Pukkala E; Rintala RJ; Pakarinen MP
    J Pediatr Surg; 2008 Apr; 43(4):602-5. PubMed ID: 18405703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal and gastric cancer incidence and mortality in alendronate users.
    Abrahamsen B; Pazianas M; Eiken P; Russell RG; Eastell R
    J Bone Miner Res; 2012 Mar; 27(3):679-86. PubMed ID: 22113985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data.
    Horwhat JD; Baroni D; Maydonovitch C; Osgard E; Ormseth E; Rueda-Pedraza E; Lee HJ; Hirota WK; Wong RK
    Am J Gastroenterol; 2007 Mar; 102(3):497-506. PubMed ID: 17156135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social inequality and incidence of and survival from cancers of the oesophagus, stomach and pancreas in a population-based study in Denmark, 1994-2003.
    Baastrup R; Sørensen M; Hansen J; Hansen RD; Würtzen H; Winther JF
    Eur J Cancer; 2008 Sep; 44(14):1962-77. PubMed ID: 18657967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.
    Cooper GS; Kou TD; Chak A
    Am J Gastroenterol; 2009 Jun; 104(6):1356-62. PubMed ID: 19491849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
    Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux.
    Erichsen R; Robertson D; Farkas DK; Pedersen L; Pohl H; Baron JA; Sørensen HT
    Clin Gastroenterol Hepatol; 2012 May; 10(5):475-80.e1. PubMed ID: 22245963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic follow-up of 383 patients with colorectal adenoma: an observational study in daily practice.
    Jonkers D; Ernst J; Pladdet I; Stockbrügger R; Hameeteman W
    Eur J Cancer Prev; 2006 Jun; 15(3):202-10. PubMed ID: 16679862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients.
    Rulyak SJ; Lieberman DA; Wagner EH; Mandelson MT
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):470-6; quiz 407. PubMed ID: 17270502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer in esophagus and cardia--incidence trends in Denmark].
    Gregersen LH; Friis S; Olsen JH
    Ugeskr Laeger; 2008 Apr; 170(17):1460-4. PubMed ID: 18462626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
    Vieth M; Schubert B; Lang-Schwarz K; Stolte M
    Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
    Wei S; Tian J; Song X; Chen Y
    Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.